Anti-Proliferative and Apoptosis-Promoting Effect of microRNA-125b on Pancreatic Cancer by Targeting NEDD9 via PI3K/AKT Signaling

Anti-Proliferative and Apoptosis-Promoting Effect of microRNA-125b on Pancreatic Cancer by Targeting NEDD9 via PI3K/AKT Signaling

Yuzheng Xue,1,* Yao Zhong,1,* Tielong Wu,1 Yingyue Sheng,1 Yuanyuan Dai,1 Lingling Xu,1 Chuanqing Bao2 1Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi 214041, Jiangsu, People’s Republic of China; 2Department of Gastrointestinal Surgery, Affiliated Hospital...

Full description

Bibliographic Details
Main Authors:	Xue Y, Zhong Y, Wu T, Sheng Y, Dai Y, Xu L, Bao C
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-08-01
Series:	Cancer Management and Research
Subjects:	mir-125b pancreatic ductal adenocarcinoma apoptosis nedd9 pi3k/akt
Online Access:	https://www.dovepress.com/anti-proliferative-and-apoptosis-promoting-effect-of-microrna-125b-on--peer-reviewed-article-CMAR

Similar Items

Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC)
by: Petra Radulović, et al.
Published: (2018-08-01)

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
by: Al-Ali, R., et al.
Published: (2022)

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
by: Al-Ali, R., et al.
Published: (2022)

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
by: Daniela Massihnia, et al.
Published: (2017-01-01)

MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt
by: Wenzhuo Yang, et al.
Published: (2016-05-01)

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway
by: Ke Fu, et al.
Published: (2020-05-01)

Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer
by: Silvia Grassilli, et al.
Published: (2020-09-01)

Endovascular implantation of iodine-125 seed strand combined and stent placement for locally advanced pancreatic ductal adenocarcinoma with vascular invasion: a prospective single-arm pilot study
by: Linlin Wu, et al.
Published: (2020-10-01)

Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis
by: Xiaofeng Guo, et al.
Published: (2020-05-01)

Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
by: Cigdem Usul Afsar, et al.
Published: (2018-12-01)

MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
by: Run-Fen Cheng, et al.
Published: (2016-07-01)

MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway
by: Guanghui Zhu, et al.
Published: (2018-08-01)

miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway
by: Qinxue Cao, et al.
Published: (2020-04-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
by: Qing Hua, et al.
Published: (2021-07-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Modulation of FoxO1 Expression by miR-21 to Promote Growth of Pancreatic Ductal Adenocarcinoma
by: Weifeng Song, et al.
Published: (2015-01-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
by: Ye Lu, et al.
Published: (2021-08-01)

A Highly Responsive Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Rare Case Report
by: Xu Y, et al.
Published: (2021-02-01)

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma
by: J. Zhao, et al.
Published: (2016-07-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018-01-01)

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
by: Maria Diab, et al.
Published: (2016-06-01)

microRNA based prognostic biomarkers in pancreatic Cancer
by: Shixiang Guo, et al.
Published: (2018-05-01)

Diagnosis of the pancreatic cancer
by: Przemysław Raczkiewicz, et al.
Published: (2021-09-01)

Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01)

MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2
by: Zhou Y, et al.
Published: (2020-09-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Selenium protects against LPS-induced MC3T3-E1 cells apoptosis through modulation of microRNA-155 and PI3K/Akt signaling pathways
by: Yan Huang, et al.

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
by: John C. Chang, et al.
Published: (2017-03-01)

NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway
by: Zhang X, et al.
Published: (2020-11-01)

Brucein D, a Naturally Occurring Tetracyclic Triterpene Quassinoid, Induces Apoptosis in Pancreatic Cancer through ROS-Associated PI3K/Akt Signaling Pathway
by: Zheng-Quan Lai, et al.
Published: (2017-12-01)

Lobaplatin Enhances Radioactive 125I Seed-Induced Apoptosis and Anti-Proliferative Effect in Non-Small Cell Lung Cancer by Suppressing the AKT/mTOR Pathway
by: Rong J, et al.
Published: (2021-01-01)

Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma
by: Dan-ming Wei, et al.
Published: (2018-10-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Up-Regulation of circEIF6 Contributes to Pancreatic Cancer Development Through Targeting miR-557/SLC7A11/PI3K/AKT Signaling
by: Zhang T, et al.
Published: (2021-01-01)

LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway
by: Chen Luo, et al.
Published: (2021-12-01)